CYP2E1 and metabolic dysfunction-associated steatotic liver disease: Whereas the LRP6-Wnt/β-catenin-Cyp2E1 signaling pathway has been demonstrated as a contributing mechanism for the liver injury and silibinin response in NAFLD in the present study, future studies are needed to determine how important CYP2E1 is.